Abivax Provides 2026 Corporate Outlook New market insights indicate significant future expansion of the ulcerative colitis (UC) market, with ...

Abivax shares have risen steadily since late July, when the company traded at 42.6 euros. The company announced positive Phase 3 trial results for a drug to treat inflammatory bowel disease on July 23 ...

Making in 2025. ABIVAX Societe Anonyme (NASDAQ:ABVX) is last year’s top performer. Abivax skyrocketed by 1,742.28 percent in ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sanofi (SNYNF – Research Report) and Abivax SA Sponsored ADR (ABVX – Research ...

ABIVAX Société Anonyme (NASDAQ:ABVX) is one of the hottest large-cap stocks of 2025. On December 16, Piper Sandler raised the ...

French biotech moves on with the late stage drug development, after publishing impressive clinical trial results of ABX464 for treatment of colitis and hinting its potential in Crohn’s disease. Abivax ...

ABIVAX Société Anonyme (ENXTPA:ABVX) has drawn attention after recent trading saw its shares close at €103.40, with returns over the past 3 months and the past year contrasting with a weaker ...

Sofinnova Partners has invested €12 million ($14 million) in Abivax, securing itself more than 10% of the company. The investment extends Abivax’s cash runway out to the middle of 2020, buying the ...

ABIVAX Société Anonyme (NASDAQ:ABVX) is one of the best emerging technology stocks to invest in. On December 18, Guggenheim ...

Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic ...

PARIS, France, October 20, 2023 – 3:00 p.m. (CEST) – Abivax SA (Euronext Paris: FR0012333284 – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing ...

Abivax S.A. FR:ABVX has increased the size of its global offering to 20.33 million shares from 18.68 million shares as part of its uplisting to the Nasdaq under the ticker symbol “ABVX” from Euronext ...